Havel M - Search Results

1

The progression of mild acute cardiac rejection evaluated by risk factor analysis. The impact of maintenance steroids and serum creatinine.

Laufer G, Laczkovics A, Wollenek G, Buxbaum P, Seitelberger R, Holzinger C, Horvat R, Havel M, Wolner E. Laufer G, et al. Among authors: havel m. Transplantation. 1991 Jan;51(1):184-9. doi: 10.1097/00007890-199101000-00029. Transplantation. 1991. PMID: 1987689

2

Cytomegalovirus hyperimmunoglobulin prophylaxis in the prevention of cytomegalovirus infection in immunosuppressed heart transplant patients.

Havel M, Teufelsbauer H, Laczkovics A, Kurz R, Wolner E. Havel M, et al. Transplant Proc. 1990 Aug;22(4):1805-6. Transplant Proc. 1990. PMID: 2167533 No abstract available.

3

Neopterin as a new marker to detect acute rejection after heart transplantation.

Havel M, Laczkovics A, Teufelsbauer H, Müller MM, Wolner E. Havel M, et al. J Heart Transplant. 1989 Mar-Apr;8(2):167-70. J Heart Transplant. 1989. PMID: 2651621

4

Prophylactic use of hyperimmunoglobulin for cytomegalovirus infection in heart transplantation.

Havel MP, Laczkovics AM, Wolner E, Kurz RW, Popow-Kraupp T. Havel MP, et al. Clin Ther. 1989 Jul-Aug;11(4):472-8. Clin Ther. 1989. PMID: 2550134

5

Decreasing use of donated blood and reduction of bleeding after orthotopic heart transplantation by use of aprotinin.

Havel M, Owen AN, Simon P, Teufelsbauer H, Zwoelfer W, Laczkovics A, Wolner E. Havel M, et al. J Heart Lung Transplant. 1992 Mar-Apr;11(2 Pt 1):348-9. J Heart Lung Transplant. 1992. PMID: 1374266 Clinical Trial.

6

[Orthotopic heart transplantation at the 2d Surgical Department of the University of Vienna: 4-year experience].

Laufer G, Havel M, Holzinger C, Wollenek G, Laczkovics A, Wolner E. Laufer G, et al. Among authors: havel m. Wien Klin Wochenschr. 1989 Jan 20;101(2):53-7. Wien Klin Wochenschr. 1989. PMID: 2644739 German.

7

Beta 2-microglobulin. A reliable parameter for differentiating between graft rejection and severe infection after cardiac transplantation.

Teufelsbauer H, Prischl FC, Havel M, Holzinger C, Lion T, Schwarzmeier JD, Laczkovics A. Teufelsbauer H, et al. Among authors: havel m. Circulation. 1989 Dec;80(6):1681-8. doi: 10.1161/01.cir.80.6.1681. Circulation. 1989. PMID: 2688973

8

Role of beta 2-microglobulin in the monitoring of patients after orthotopic heart transplantation.

Prischl F, Teufelsbauer H, Havel M, Laczkovics A, Wolner E, Schwarzmeier J. Prischl F, et al. Among authors: havel m. Bibl Cardiol. 1988;(43):111-5. Bibl Cardiol. 1988. PMID: 3067708 No abstract available.

9

Ciclosporin dose-response relationship in heart transplant recipients as calculated from HPLC determinations.

Hamilton G, Havel M, Laczkovics A, Mühlbacher F. Hamilton G, et al. Among authors: havel m. Bibl Cardiol. 1988;(43):39-41. Bibl Cardiol. 1988. PMID: 3067721 No abstract available.

10

Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood.

Havel M, Grabenwöger F, Schneider J, Laufer G, Wollenek G, Owen A, Simon P, Teufelsbauer H, Wolner E. Havel M, et al. J Thorac Cardiovasc Surg. 1994 Mar;107(3):807-10. J Thorac Cardiovasc Surg. 1994. PMID: 7510351 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters